Comparative Evaluation of Indirect Immunofluorescence and NS-1-Based ELISA to Determine Zika Virus-Specific IgM

Comparative Evaluation of Indirect Immunofluorescence and NS-1-Based ELISA to Determine Zika Virus-Specific IgM

Differential diagnosis of the Zika virus (ZIKV) is hampered by cross-reactivity with other flaviviruses, mainly dengue viruses. The aim of this study was to compare two commercial methods for detecting ZIKV immunoglobulin M (IgM), an indirect immunofluorescence (IIF) and an enzyme immunoassay (ELISA...

Full description

Bibliographic Details
Main Authors:	Fernando De Ory, María Paz Sánchez-Seco, Ana Vázquez, María Dolores Montero, Elena Sulleiro, Miguel J. Martínez, Lurdes Matas, Francisco J. Merino, Working Group for the Study of Zika Virus Infections
Format:	Article
Language:	English
Published:	MDPI AG 2018-07-01
Series:	Viruses
Subjects:	Zika virus dengue viruses flavivirus ELISA indirect immunofluorescence plaque reduction neutralization test polymerase chain reaction cross-reactions
Online Access:	http://www.mdpi.com/1999-4915/10/7/379

Similar Items

Zika Virus NS2A-Mediated Virion Assembly
by: Xianwen Zhang, et al.
Published: (2019-10-01)

Seroprevalence of Zika Virus in Wild African Green Monkeys and Baboons
by: Connor R. Buechler, et al.
Published: (2017-04-01)

Current trends in Zika vaccine development
by: Francisco A. Lagunas-Rangel, et al.
Published: (2017-07-01)

Flavivirus Zika NS4A protein forms large oligomers in liposomes and in mild detergent
by: Surya, Wahyu, et al.
Published: (2024)

Zika virus: an alert for prevention
by: Deysi Licourt Otero, et al.
Published: (2018-05-01)

Etymologia: Zika Virus
Published: (2014-06-01)

Genetic and biochemical characterizations of Zika virus NS2A protein
by: Xianwen Zhang, et al.
Published: (2019-01-01)

Zika Virus Outside Africa
by: Edward B. Hayes
Published: (2009-09-01)

Engineered NS1 for Sensitive, Specific Zika Virus Diagnosis from Patient Serology
by: Thai Leong Yap, et al.
Published: (2021-05-01)

Zika Virus Infection, Cambodia, 2010
by: Vireak Heang, et al.
Published: (2012-02-01)

Zika virus infection: The resurgence of a neglected disease
by: Tushar Kambale, et al.
Published: (2016-01-01)

Zika virus as an emerging arbovirus of international public health concern
by: Samira Vaziri, et al.
Published: (2022-10-01)

Zika Virus from the Perspective of Observational Studies: a Review
by: Tayyab Saleem, et al.
Published: (2023-02-01)

Two Infants with Presumed Congenital Zika Syndrome, Brownsville, Texas, USA, 2016–2017
by: Ashley Howard, et al.
Published: (2018-04-01)

Zika Virus Inhibitors Based on a 1,3-Disubstituted 1<i>H</i>-Pyrazolo[3,4-<i>d</i>]pyrimidine-amine Scaffold
by: Eunkyung Jung, et al.
Published: (2022-09-01)

Evaluation of the LIAISON XL Zika Capture IgM II for the Diagnosis of Zika Virus Infections
by: Mayte Pérez-Olmeda, et al.
Published: (2020-01-01)

The Application and Interpretation of IgG Avidity and IgA ELISA Tests to Characterize Zika Virus Infections
by: Fátima Amaro, et al.
Published: (2019-02-01)

Inactivation and Environmental Stability of Zika Virus
by: Janis A. Müller, et al.
Published: (2016-09-01)

Zika Virus Seroprevalence, French Polynesia, 2014–2015
by: Maite Aubry, et al.
Published: (2017-04-01)

The latest advancements in Zika virus vaccine development
by: Lanying Du, et al.
Published: (2017-10-01)

Outbreak of Exanthematous Illness Associated with Zika, Chikungunya, and Dengue Viruses, Salvador, Brazil
by: Cristiane W. Cardoso, et al.
Published: (2015-12-01)

Microcefalia e Zika Vírus: características e associações
by: Cynthia Molina Bastos, et al.
Published: (2016-08-01)

A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine
by: Yujiao Yang, et al.
Published: (2017-03-01)

A new global threat for the public safety: Zika virus
by: Simona Bicheru, et al.
Published: (2016-04-01)

The Chimeric Chaoyang-Zika Vaccine Candidate Is Safe and Protective in Mice
by: Hao-Long Dong, et al.
Published: (2024-02-01)

Attenuation of Zika Virus by Passage in Human HeLa Cells
by: Li Li, et al.
Published: (2019-08-01)

4,7-Disubstituted 7<i>H</i>-Pyrrolo[2,3-d]pyrimidines and Their Analogs as Antiviral Agents against Zika Virus
by: Ruben Soto-Acosta, et al.
Published: (2021-06-01)

Zika Virus IgM Detection and Neutralizing Antibody Profiles 12–19 Months after Illness Onset
by: Isabel Griffin, et al.
Published: (2019-02-01)

Phylogeny of Zika Virus in Western Hemisphere, 2015
by: Robert Lanciotti, et al.
Published: (2016-05-01)

Serological Evidence of Zika Virus Circulation in Burkina Faso
by: Bachirou Tinto, et al.
Published: (2022-06-01)

Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines
by: Cameron Adams, et al.
Published: (2021-12-01)

Dengue, West Nile, and Zika Viruses: Potential Novel Antiviral Biologics Drugs Currently at Discovery and Preclinical Development Stages
by: Ivo C. Martins, et al.
Published: (2022-11-01)

Febrile or Exanthematous Illness Associated with Zika, Dengue, and Chikungunya Viruses, Panama
by: Dimelza Araúz, et al.
Published: (2016-08-01)

Evidence of Zika Virus Infection in Pigs and Mosquitoes, Mexico
by: Daniel Nunez-Avellaneda, et al.
Published: (2021-02-01)

Virtual Screening for Potential Inhibitors of NS3 Protein of Zika Virus
by: Maheswata Sahoo, et al.
Published: (2016-09-01)

Effects of Statin Combinations on Zika Virus Infection in Vero Cells
by: Erica Españo, et al.
Published: (2022-12-01)

Protective to a T: The Role of T Cells during Zika Virus Infection
by: Ryan D. Pardy, et al.
Published: (2019-08-01)

Structural basis of Zika virus helicase in recognizing its substrates
by: Hongliang Tian, et al.
Published: (2016-07-01)

Recent Advances in Zika Virus Vaccines
by: Himanshu Garg, et al.
Published: (2018-11-01)

Seroprevalence of Zika Virus in Amphawa District, Thailand, after the 2016 Pandemic
by: Salin Sirinam, et al.
Published: (2022-02-01)